MTR and breast cancer: The thymidylate synthase (TYMS), 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR), and methionine synthase reductase (MTRR) are suitable genes to study the role of variants of genes involved in the metabolism of folate in the BC risk.